{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:53:12Z","timestamp":1768870392617,"version":"3.49.0"},"reference-count":15,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.5334\/tohm.1134","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:12:06Z","timestamp":1768824726000},"source":"Crossref","is-referenced-by-count":0,"title":["High Dose AbobotulinumtoxinA for Blepharospasm: A Case Report on the Safety and Efficacy of 500 Units of AbobotulinumtoxinA"],"prefix":"10.5334","volume":"16","author":[{"given":"Kate","family":"Santoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5527-4594","authenticated-orcid":false,"given":"Ava","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-0443","authenticated-orcid":false,"given":"Khashayar","family":"Dashtipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","reference":[{"key":"key20260119121151_B1","first-page":"359","article-title":"Dystomia 3. Summary and conclusions","volume":"78","year":"1998","journal-title":"Advances in Neurology"},{"key":"key20260119121151_B2","first-page":"91","article-title":"Ophthalmologic causes of blepharospasm","volume":"49","year":"1988","journal-title":"Advances in neurology"},{"key":"key20260119121151_B3","first-page":"259","article-title":"The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer\u2019s cramp, and torticollis, or axial dystonia)","volume":"14","year":"1976","journal-title":"Adv Neurol"},{"key":"key20260119121151_B4","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.3389\/dyst.2022.10359","article-title":"Clinical features and evolution of blepharospasm: A multicenter international cohort and systematic literature review","volume":"1","year":"2022","journal-title":"Dystonia"},{"issue":"4","key":"key20260119121151_B5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/ajp.155.4.555","article-title":"Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm","volume":"155","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"S1","key":"key20260119121151_B6","article-title":"Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): development, insights, and impact","volume":"102","year":"2023","journal-title":"Medicine"},{"issue":"7","key":"key20260119121151_B7","first-page":"520","article-title":"Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox","volume":"10","year":"2008","journal-title":"Isr Med Assoc J"},{"issue":"12","key":"key20260119121151_B8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport\u00ae), OnabotulinumtoxinA (Botox\u00ae), and IncobotulinumtoxinA (Xeomin\u00ae) neurotoxin content and potential implications for duration of response in patients","volume":"10","year":"2018","journal-title":"Toxins"},{"issue":"8","key":"key20260119121151_B9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm\u2014a randomized trial","volume":"26","year":"2011","journal-title":"Movement disorders"},{"key":"key20260119121151_B10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/OPTH.S13978","article-title":"Profile of Xeomin\u00ae(incobotulinumtoxinA) for the treatment of blepharospasm","year":"2011","journal-title":"Clinical Ophthalmology"},{"issue":"19","key":"key20260119121151_B11","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED] Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","year":"2016","journal-title":"Neurology"},{"key":"key20260119121151_B12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5334\/tohm.273","article-title":"Systematic literature review of abobotulinumtoxina in clinical trials for blepharospasm and hemifacial spasm","volume":"5","year":"2015","journal-title":"Tremor and Other Hyperkinetic Movements"},{"issue":"5","key":"key20260119121151_B13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","article-title":"Efficacy and safety of purified botulinum toxin type A (Dysport\u00ae) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial","volume":"14","author":"Group DBEBS","year":"2008","journal-title":"Parkinsonism & related disorders"},{"issue":"4","key":"key20260119121151_B14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","year":"1997","journal-title":"Graefe\u2019s archive for clinical and experimental ophthalmology"},{"issue":"6","key":"key20260119121151_B15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4: 1","volume":"12","year":"1997","journal-title":"Movement Disorders"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:12:08Z","timestamp":1768824728000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.1134\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,19]]}},"alternative-id":["10.5334\/tohm.1134"],"URL":"https:\/\/doi.org\/10.5334\/tohm.1134","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"4"}}